News
18.05.2022
PMA Insights: Week 20

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
11.05.2022
How are countries in South-East Asia establishing ...

Introduction Health Technology Assessment (HTA) implementation has been historically slow in Asia co...

Read more
04.05.2022
PMA Insights: Week 18

A short, 60 seconds read that summarises 4 handpicked articles that are worth reading about: Regulat...

Read more
Articles
03.05.2022
What are the top 5 considerations to be aware of b...

Introduction: Brazil is a market of 210 million people Brazil is the largest country in South Americ...

Read more
Insider Insights
15.03.2022
NICE presents three-year international strategy

Two NICE teams (NICE International and the Science Policy and Research Programme) will act as key en...

Read more
Articles
10.03.2022
Orphan status higher prices in the UK

Beyond the regulatory level, a well-recognised challenge for companies launching drugs in orphan dis...

Read more
Articles
01.03.2022
China's most recent NRDL update

In December 2021, China once again updated its National Reimbursed Drugs List (NRDL).

Read more
Insider Insights
28.02.2022
UK first rare disease action plan

On 28th February 2022, Health and Social Care Secretary Sajid Javid launched England’s first Rare...

Read more
Articles
24.02.2022
Patient reported outcomes

This educational blog explores what PROs are, explains why they of growing importance in the digital...

Read more
Articles
07.02.2022
Advanced therapy medicinal product withdrawals

Advanced therapy medicinal products (ATMPs) are medicinal products for human use that are based on l...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.